Baird Financial Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Buy |
+4,667
| New | +$243K | ﹤0.01% | 1654 |
|
|
2024
Q4 | – | Sell |
-1,374
| Closed | -$98.8K | – | 1764 |
|
|
2024
Q3 | $98.8K | Sell |
1,374
-2,352
| -63% | -$169K | ﹤0.01% | 1708 |
|
|
2024
Q2 | $258K | Sell |
3,726
-48,505
| -93% | -$3.36M | ﹤0.01% | 1601 |
|
|
2024
Q1 | $4.18M | Buy |
52,231
+2,468
| +5% | +$198K | 0.01% | 713 |
|
|
2023
Q4 | $5.45M | Buy |
49,763
+15,347
| +45% | +$1.68M | 0.01% | 642 |
|
|
2023
Q3 | $3.47M | Buy |
34,416
+427
| +1% | +$43.1K | 0.01% | 734 |
|
|
2023
Q2 | $4.62M | Buy |
33,989
+894
| +3% | +$121K | 0.01% | 642 |
|
|
2023
Q1 | $3.44M | Buy |
33,095
+1,033
| +3% | +$107K | 0.01% | 709 |
|
|
2022
Q4 | $2.84M | Sell |
32,062
-281
| -0.9% | -$24.9K | 0.01% | 757 |
|
|
2022
Q3 | $2.59M | Buy |
32,343
+310
| +1% | +$24.9K | 0.01% | 749 |
|
|
2022
Q2 | $3.07M | Buy |
32,033
+1,391
| +5% | +$133K | 0.01% | 705 |
|
|
2022
Q1 | $4.55M | Buy |
30,642
+2,622
| +9% | +$390K | 0.01% | 649 |
|
|
2021
Q4 | $3.97M | Buy |
28,020
+7,708
| +38% | +$1.09M | 0.01% | 682 |
|
|
2021
Q3 | $2.66M | Buy |
20,312
+7,022
| +53% | +$919K | 0.01% | 827 |
|
|
2021
Q2 | $1.83M | Buy |
13,290
+3,754
| +39% | +$516K | ﹤0.01% | 966 |
|
|
2021
Q1 | $1.25M | Buy |
+9,536
| New | +$1.25M | ﹤0.01% | 1047 |
|
|
2018
Q4 | – | Sell |
-7,414
| Closed | -$587K | – | 1282 |
|
|
2018
Q3 | $587K | Buy |
+7,414
| New | +$587K | ﹤0.01% | 1000 |
|